(Q24203667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

1 reference

1 reference

1 reference

4

Carlo Di Pietrantonj

Carlo

Di Pietrantonj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

1

Vittorio Demicheli

Vittorio

Demicheli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

2

Alessandro Rivetti

Alessandro

Rivetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

author name string

Maria Grazia Debalini

series ordinal

3

author given names

Maria Grazia

author last names

Debalini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

language of work or name

English

0 references

publication date

15 February 2012

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

page(s)

CD004407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccine and idiopathic thrombocytopaenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Evaluation of a trivalent measles, mumps, rubella vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Timing of routine immunisations and subsequent hay fever risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccinations, infections and antibacterials in the first grass pollen season of life and risk of later hayfever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Childhood vaccinations and risk of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No effect of MMR withdrawal on the incidence of autism: a total population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Childhood vaccination and type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles-mumps-rubella vaccination and asthma-like disease in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccination history and risk of childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

A population-based study of measles, mumps, and rubella vaccination and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Neurologic disorders after measles-mumps-rubella vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccination and Allergic Disease: A Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No evidence of an association between MMR vaccine and gait disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Serological evaluation of a measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccination and pervasive developmental disorders: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR Vaccination and Febrile Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Risk of serious neurologic disease after immunization of young children in Britain and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles in the United Kingdom: can we eradicate it by 2010?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

21 January 2018

MMR vaccine and autism.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Is the severity of mumps related to the number of doses of mumps-containing vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Combined Live Measles, Mumps, and Rubella Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Safety of routine childhood vaccinations. An epidemiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Retrospective measles outbreak investigation: Sudan, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

A response to the article on the association between paracetamol/acetaminophen: use and autism by Stephen T. Schultz.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Description of two measles outbreaks in the Lazio Region, Italy (2006-2007). Importance of pockets of low vaccine coverage in sustaining the infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Time trends in autism and in MMR immunization coverage in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Recent resurgence of mumps in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Wakefield was dishonest and irresponsible over MMR research, says GMC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Lancet retracts Wakefield's MMR paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Case series analysis of adverse reactions to vaccines: a comparative evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR and autism: further evidence against a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccines and autism: a tale of shifting hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles outbreak in Tanzania, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Reporting of MMR evidence in professional publications: 1988-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Characterization of large mumps outbreak among vaccinated Palestinian refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Lack of association between measles virus vaccine and autism with enteropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

The changing epidemiology of hospitalized pediatric patients in three measles outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles vaccines and the potential for worldwide eradication of measles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Idiopathic thrombocytopenic purpura and MMR vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccine: review of benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Infant immunization and the occurrence of atopic disease in Dutch and German children: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccination and autism 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Childhood infections as risk factors for multiple sclerosis: Belgrade case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccination associated thrombocytopenic purpura in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Effectiveness of previous mumps vaccination during a summer camp outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps outbreak in the Republic of Moldova, 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR vaccination and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

A Field Trial with a Live Measles-Mumps- Rubella Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Viral antibodies in twins with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles vaccination and inflammatory bowel disease in Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps vaccine effectiveness in highly immunized populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Risk factors for mumps at a university with a large mumps outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

[Epidemiological investigation of a measles outbreak in a preschool in Incheon, Korea, 2006].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Large measles outbreak at a German public school, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps vaccine performance among university students during a mumps outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Control without separate controls: evaluation of vaccine safety using case-only methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Mumps outbreak in a highly vaccinated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

MMR: marginalised, misrepresented and rejected? Autism: a focus group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Relation between experimental and non-experimental study designs. HB vaccines: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Retraction of an interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Communicating science to the public: MMR vaccine and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Global measles elimination efforts: the significance of measles elimination in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Vaccines for measles, mumps and rubella in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Autism, inflammatory bowel disease, and MMR vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

[Resurgence of mumps in the vaccine era. Factors involved in an outbreak in Navarre, Spain, 2006-2007]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: Comparisons with injected MMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 [1998] 222-226)

21 January 2018

1 reference

12 December 2020

Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association.

1 reference

12 December 2020

Autism, viral infection and measles-mumps-rubella vaccination

1 reference

12 December 2020

Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.

1 reference

12 December 2020

1 reference

12 December 2020

Mumps and rubella eliminated from Finland

1 reference

12 December 2020

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

12 December 2020

Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

1 reference

12 December 2020

Measles, mumps, rubella vaccine: through a glass, darkly

1 reference

12 December 2020

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project

1 reference

12 December 2020

A sixty day war of words: is MMR linked to autism?

1 reference

12 December 2020

1 reference

12 December 2020

No evidence for a new variant of measles-mumps-rubella-induced autism

1 reference

12 December 2020

Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination

1 reference

12 December 2020

An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines

1 reference

12 December 2020

[Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine]

1 reference

12 December 2020

The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997

1 reference

12 December 2020

Local Subcutaneous Atrophy Following Measles, Mumps, and Rubella Vaccination

1 reference

12 December 2020

Measles, mumps, and rubella vaccination and autism

1 reference

12 December 2020

Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996.

1 reference

12 December 2020

Clinical Evaluation of a New Measles-Mumps-Rubella Trivalent Vaccine

1 reference

12 December 2020

A comparative study of 3 different types of trivalent measles-mumps-rubella vaccine

1 reference

12 December 2020

A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism

1 reference

12 December 2020

Outbreak of measles amongst vaccinated children in a slum of Chandigarh.

1 reference

12 December 2020

Outbreak of mumps in a vaccinated child population: a question of vaccine failure?

1 reference

12 December 2020

[Must we expect an epidemic of measles in the near future in Southern Tyrol?]

1 reference

12 December 2020

Asthma and vaccination history in a young adult cohort

1 reference

12 December 2020

The effectiveness of the mumps component of the MMR vaccine: a case control study

1 reference

12 December 2020

Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria

1 reference

12 December 2020

Measles in Saudi Arabia: from control to elimination.

1 reference

12 December 2020

Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy

1 reference

12 December 2020

The impact of MMR vaccine on mumps infection in England and Wales

1 reference

12 December 2020

A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.

1 reference

12 December 2020

Mumps in a boarding school: description of an outbreak and control measures

1 reference

12 December 2020

Non-preventable mumps outbreaks in schoolchildren in Catalonia

1 reference

12 December 2020

Meningoencephalitis associated with MMR vaccine

1 reference

12 December 2020

Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom

1 reference

12 December 2020

Analysis of the cause of increased measles incidence in Xinjiang, China in 2004

1 reference

12 December 2020

Outbreak of measles in primary school students with high first dose MMR vaccination coverage

1 reference

12 December 2020

The end of the road for the campaign against MMR.

1 reference

12 December 2020

[Study on the epidemiological characteristics of rubella from 1990-2006 in Shanghai].

1 reference

12 December 2020

Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children

1 reference

12 December 2020

Mumps outbreak in young adults following a festival in Austria, 2006

1 reference

12 December 2020

Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006

1 reference

12 December 2020

Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants

1 reference

12 December 2020

Adverse events following measles-mumps-rubella and measles vaccinations in college students

1 reference

12 December 2020

An increase in the number of mumps cases in the Czech Republic, 2005-2006.

1 reference

12 December 2020

Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations

1 reference

12 December 2020

Risk of seizures after measles-mumps-rubella immunization

1 reference

12 December 2020

Egg hypersensitivity and measles-mumps-rubella vaccine administration

1 reference

12 December 2020

Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006

1 reference

12 December 2020

Measles vaccines: WHO position paper

1 reference

12 December 2020

Impact of a measles elimination strategy on measles incidence in Malaysia.

1 reference

12 December 2020

RETRACTION: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

1 reference

12 December 2020

Adverse reactions and mumps, measles and rubella vaccine.

1 reference

12 December 2020

[Surveillance of adverse events following immunization of MMR in Changning District of Shanghai]

1 reference

12 December 2020

A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population

1 reference

12 December 2020

EFFECTIVENESS OF MEASLES VACCINATION FOR CONTROL OF EXPOSED CHILDREN

1 reference

12 December 2020

The rising incidence of type 1 diabetes mellitus and the role of environmental factors--three decade experience in a primary care health center in Saudi Arabia

1 reference

12 December 2020

[The clinico-immunological evaluation of a bivalent vaccine against measles and rubella]

1 reference

12 December 2020

Lower long-term immunogenicity of mumps component after MMR vaccine

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus

1 reference

12 December 2020

A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies

1 reference

12 December 2020

Reactions after MMR vaccination

1 reference

12 December 2020

Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine

1 reference

12 December 2020

[Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]

1 reference

12 December 2020

Surveillance of symptoms following MMR vaccine in children

1 reference

12 December 2020

An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants

1 reference

12 December 2020

Evaluation of a combined measles-mumps-rubella-chickenpox vaccine

1 reference

12 December 2020

Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines

1 reference

12 December 2020

Field evaluation of vaccine efficacy

1 reference

12 December 2020

Adverse events following immunization with DTP vaccine

1 reference

12 December 2020

[Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella]

1 reference

12 December 2020

Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.

1 reference

12 December 2020

A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile

1 reference

12 December 2020

Vaccination against measles, mumps and rubella--together or separately?

1 reference

12 December 2020

Studies on active immunization in measles, mumps and rubella

1 reference

12 December 2020

Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT

1 reference

12 December 2020

Convulsions after measles immunisation

1 reference

12 December 2020

Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children

1 reference

12 December 2020

The safety of egg-containing vaccines for egg-allergic patients

1 reference

12 December 2020

Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination

1 reference

12 December 2020

Optic neuritis complicating measles, mumps, and rubella vaccination

1 reference

12 December 2020

Field trial of trivalent measles-rubella-mumps vaccine in Japan

1 reference

12 December 2020

Malignant histiocytosis with slow clinical course

1 reference

12 December 2020

[Adverse effects of Virivac]

1 reference

12 December 2020

Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus.

1 reference

12 December 2020

Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic

1 reference

12 December 2020

Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan

1 reference

12 December 2020

Simultaneous administration at different dosages of attenuated live virus vaccines against measles, mumps and rubella

1 reference

12 December 2020

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

12 December 2020

Illness after measles-mumps-rubella vaccination

1 reference

12 December 2020

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity

1 reference

12 December 2020

Systemic reactions to measles-mumps-rubella vaccine skin testing

1 reference

12 December 2020

Immunogenicity and reactogenicity of indigenously produced MMR vaccine

1 reference

12 December 2020

Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule

1 reference

12 December 2020

Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention

1 reference

12 December 2020

Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella

1 reference

12 December 2020

Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain

1 reference

12 December 2020

Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls.

1 reference

12 December 2020

Autism, inflammatory bowel disease, and MMR vaccine

1 reference

12 December 2020

Autism, inflammatory bowel disease, and MMR vaccine

1 reference

12 December 2020

Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)

1 reference

12 December 2020

The interruption of transmission of indigenous measles in the United States during 1993

1 reference

12 December 2020

Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases

1 reference

12 December 2020

Safety reporting in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD004407.PUB3

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3220598

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

release_zn2gjgz4nbfcpduf56wojkvoiu

13 May 2020

Fatcat ID

0 references

OpenCitations bibliographic resource ID

3220598

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6458016&resulttype=core&format=json

13 May 2020

PubMed publication ID

22336803

1 reference